Page last updated: 2024-10-31

moclobemide and Bradyarrhythmia

moclobemide has been researched along with Bradyarrhythmia in 1 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Research Excerpts

ExcerptRelevanceReference
"Serotonin syndrome is caused by excess serotonin in the central nervous system."1.37[Serotonin syndrome in the course of drug-poisoning--case presentation]. ( Kostek, H; Kujawa, A; Majewska, M; Pyra, E; Szponar, J, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Majewska, M1
Szponar, J1
Pyra, E1
Kostek, H1
Kujawa, A1

Other Studies

1 other study available for moclobemide and Bradyarrhythmia

ArticleYear
[Serotonin syndrome in the course of drug-poisoning--case presentation].
    Przeglad lekarski, 2011, Volume: 68, Issue:8

    Topics: Alcoholic Intoxication; Alkaloids; Azocines; Bradycardia; Cyclohexanols; Depressive Disorder; Electr

2011